Trademark: 79230988
Word
MYOVANT
Status
Registered
Status Code
700
Status Date
Tuesday, October 2, 2018
Serial Number
79230988
Registration Number
5572795
Registration Date
Tuesday, October 2, 2018
Mark Type
4000
Filing Date
Friday, February 9, 2018
Published for Opposition
Tuesday, July 17, 2018

Trademark Owner History
Myovant Sciences GmbH - Original Registrant

Classifications
5 Pharmaceutical and biological preparations for medical use for the treatment of gynecological disorders, endocrine-related disorders, uterine fibroids, endometriosis, infertility, cancer, and prostate cancer
44 Information services in the field of health and medicine and provision of information regarding medicines and drugs for medical use via a website

Trademark Events
Oct 2, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Feb 2, 2019
Final Decision Transaction Processed By Ib
Jan 15, 2019
Final Disposition Notice Sent To Ib
Jan 15, 2019
Final Disposition Processed
Jan 2, 2019
Final Disposition Notice Created, To Be Sent To Ib
Oct 2, 2018
Registered-Principal Register
Jul 17, 2018
Official Gazette Publication Confirmation E-Mailed
Jul 17, 2018
Published For Opposition
Jun 27, 2018
Notification Of Notice Of Publication E-Mailed
Jun 23, 2018
Refusal Processed By Ib
Jun 15, 2018
New Representative At Ib Received
Jun 12, 2018
Approved For Pub - Principal Register
Jun 11, 2018
Teas/Email Correspondence Entered
Jun 11, 2018
Correspondence Received In Law Office
Jun 11, 2018
Teas Response To Office Action Received
Jun 5, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Jun 5, 2018
Refusal Processed By Mpu
May 26, 2018
Non-Final Action (Ib Refusal) Prepared For Review
May 25, 2018
Non-Final Action Written
May 24, 2018
Assigned To Examiner
May 4, 2018
Application Filing Receipt Mailed
May 2, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
May 2, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 30, 2018
New Application Office Supplied Data Entered
Apr 26, 2018
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24